Lv2
160 积分 2026-04-14 加入
Enhanced paclitaxel oral delivery by astragalus polysaccharide-based nanoplatform for triple-negative breast cancer treatment
1天前
已完结
Nanoparticle Albumin-Bound Paclitaxel Is Superior to Liposomal Paclitaxel in The Neoadjuvant Treatment of Breast Cancer
1天前
已完结
Nanoparticle albumin-bound paclitaxel is superior to liposomal paclitaxel in the neoadjuvant treatment of breast cancer
1天前
已关闭
Nab-paclitaxel vs paclitaxel liposome for advanced breast cancer: real-world efficacy and safety analysis
1天前
已完结
Integrative co-delivery platforms for paclitaxel: Advancing synergistic breast cancer therapy
1天前
已关闭
Sequencing antibody–drug conjugates in metastatic breast cancer: A systematic review
1个月前
已完结
Efficacy of tucatinib, trastuzumab, and capecitabine (TTC) following trastuzumab-deruxtecan (T-DXd) in HER2-positive metastatic breast cancer (MBC): Updated results and subgroup analyses from the UNICANCER multicenter retrospective cohort
1个月前
已关闭
Clinical benefit of post-trastuzumab deruxtecan treatment in patients with HER 2-positive unresectable or metastatic breast cancer: A single-institution retrospective observational study
1个月前
已完结
Resistance mechanisms and post-trastuzumab deruxtecan (T-DXd) strategies in HER2+ and HER2-low breast cancer: From biology to clinical practice
1个月前
已完结
Outcomes of subsequent treatment regimens after trastuzumab deruxtecan in patients with metastatic breast cancer
1个月前
已完结
皖公网安备34019202002308
